Switch to:
More From Other Websites
EXELIXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 16 2014
EXELIXIS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Oct 15 2014
Exelixis to Release Third Quarter 2014 Financial Results on Tuesday, November 4, 2014 Oct 14 2014
Exelixis (EXEL) Is in Oversold Territory: What's Next? Oct 03 2014
Ahead of the Bell: Exelixis shares soar Sep 29 2014
Ahead of the Bell: Exelixis shares soar Sep 29 2014
Exelixis Announces Positive Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with... Sep 29 2014
EXELIXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 25 2014
Why Exelixis (EXEL) Stock Might be a Great Pick Sep 18 2014
Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress Sep 17 2014
Exelixis to Present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9 Sep 08 2014
EXELIXIS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Sep 05 2014
Exelixis Slumps 55% on Disappointing Cabozantinib Results Sep 03 2014
Exelixis (EXEL) Enters Oversold Territory Sep 03 2014
Exelixis Plunges On Drug Trial Failure; Investors See Potential Sep 02 2014
After the Exelixis Implosion, Is There Anything Left Ahead? Sep 02 2014
Why Exelixis (EXEL) Stock Plunged to a One-Year Low Today Sep 02 2014
Exelixis Drug Fails Pivotal Prostate Cancer Study Sep 02 2014
Ahead of the Bell: Exelixis shares tumble Sep 02 2014
Ahead of the Bell: Exelixis shares tumble Sep 02 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK